Zydus Lifesciences has obtained a provisional license from the U.S. Food and Drug Administration on Empagliflozin and Linagliptin pills. This is a milestone in the U.S. expanding portfolio of the company. It reports about the generic Glyxambi...
Piramal Pharma Solutions announced today that it has completed its journey to global nitrosamine compliance, marking a major step in strengthening patient safety and meeting evolving international expectations for nitrosamine impurities in...
Medtronic, a worldwide leader in healthcare innovation, revealed the limited release of the Signia Circular Stapler featuring Tri-Staple technology, representing the first smart circular stapling system designed for application across the digestive
.jpeg "Thermo Fisher Unveils Hyderabad Customer and Bioprocess Hubs")
Thermo Fisher Scientific, the world leader in serving science, today inaugurated two new facilities in Hyderabad’s Genome Valley. The Bioprocess Design Center (BDC) a technology scale-up facility was set up in partnership with Govt. Of Telangana; oth
Samsung R20, Ultrasound System, Crystal Architecture, Advanced Imaging, AI Tools, Workflow Automation, LiverAssist Technology, BreastAssist AI, Automatic Measurements, Deep USFF, Fat Fraction, OLED Display, Doppler Sensitivity, Color Imaging,
The Sun Pharmaceutical Industries has secured approval from the U.S. Food and Drug Administration (FDA) for an expanded label for its immunotherapy drug UNLOXCYT (cosibelimab ipdl). The updated label authorizes UNLOXCYT for use in adults with...
The World Health Organization (WHO) has published the Integrated Drug Resistance Action Framework for HIV, hepatitis B and C, as well as sexually transmitted infections (STIs) for 2026–2030, which serves as a crucial strategy to tackle the increasing
Glenmark Pharmaceuticals has launched the world’s first nebulized triple therapy for COPD, marking a major step forward in respiratory care. The new products — Nebzmart GFB Smartules and Glenmark Airz FB Smartules — blend Glycopyrronium...
AstraZeneca’s Imfinzi has received US approval today for use with FLOT chemotherapy in adults with resectable, early-stage and locally advanced gastric and gastroesophageal junction (GEJ) cancers. The regimen includes Imfinzi before surgery...
Biogen Inc, a top global biotechnology firm, and Dayra Therapeutics, a leader in the creation of oral macrocyclic peptide treatments for various human illnesses, revealed a research partnership aimed at discovering and developing oral macrocyclic
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")